ALXN1007-APS-201 An Open-label proof of concept Phase IIa trial of ALXN1007 for the treatment of non-criteria manifestations of Antiphospholipid Syndrome
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
July 1, 2014
End Date
November 28, 2016
Administered By
Medicine, Hematology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
July 1, 2014
End Date
November 28, 2016